Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
Status:
Not yet recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The study aims at assessing the efficacy and the safety of hydrocortisone combined with
fludrocortisone compared to placebo in ICU adults with critical illness related
corticosteroid insufficiency.